Cargando…
Effects of JWA, XRCC1 and BRCA1 mRNA expression on molecular staging for personalized therapy in patients with advanced esophageal squamous cell carcinoma
BACKGROUND: DNA damage repair genes JWA, XRCC1 and BRCA1 were associated with clinical outcomes and could convert the response to the cisplatin-based therapy in some carcinomas. The synergistic effects of JWA, XRCC1 and BRCA1 mRNA expression on personalized therapy remain unknown in advanced esophag...
Autores principales: | Wei, Bin, Han, Qin, Xu, Lijuan, Zhang, Xiaohui, Zhu, Jing, Wan, Li, Jin, Yan, Qian, Zhaoye, Wu, Jingjing, Gao, Yong, Zhou, Jianwei, Chen, Xiaofei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469327/ https://www.ncbi.nlm.nih.gov/pubmed/25925371 http://dx.doi.org/10.1186/s12885-015-1364-0 |
Ejemplares similares
-
JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cells
por: Xu, W, et al.
Publicado: (2014) -
JWA regulates XRCC1 and functions as a novel base excision repair protein in oxidative-stress-induced DNA single-strand breaks
por: Wang, Shouyu, et al.
Publicado: (2009) -
Association of XRCC1, XRCC2 and XRCC3 Gene Polymorphism with Esophageal Cancer Risk
por: Kaur, Jagjeet, et al.
Publicado: (2020) -
Targeting JWA for Cancer Therapy: Functions, Mechanisms and Drug Discovery
por: Ding, Kun, et al.
Publicado: (2022) -
JWA regulates human esophageal squamous cell carcinoma and human esophageal cells through different mitogen-activated protein kinase signaling pathways
por: LIN, JIE, et al.
Publicado: (2014)